SMID vs WST · P/E 24, rev $44.9M vs P/E 35, rev $1.72B
Smith-Midland Corp (SMID) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Smith-Midland Corp (SMID) is a building materials company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported SMID revenue for 2026-06-30 was $44.9M. Net income was $2.7M. SMID currently screens at market cap $185.3M and trailing P/E 24.1.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
SMID currently screens at market cap $185.3M and trailing P/E 24.1. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the SMID and WST stock pages for the full models.
Not investment advice.